To Evaluate Improvement Effect of Subjective Symptoms of Mucotra SR Tablet in Patients With Gastritis

Efficacy and Safety of DWC20155/DWC20156 Combination Therapy in Patients With Gastritis

NCT03184415 ·Status: TERMINATED ·Phase: PHASE3

Phase II Study to Evaluate the Efficacy and Safety of GC6101A in Subjects With Gastritis

NCT02353039 ·Status: UNKNOWN ·Phase: PHASE2

Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Acute or Chronic Gastritis

NCT04341454 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Efficacy and of Stillen Tab. and to Demonstrate the Non-inferiority of Stillen Tab.

NCT01817556 ·Status: COMPLETED ·Phase: PHASE4

The Effact of Helicobacter Hylori Eradication on the Development of Gastric Mucosa Pathology

NCT04029441 ·Status: UNKNOWN

A Study To Evaluate the Feasibility of the Decentralized Clinical Trial in South Korea

NCT06005805 ·Status: COMPLETED ·Phase: NA

Study to Evaluate the Efficacy and Safety of FEXUCLUE Tablet

NCT05886933 ·Status: COMPLETED

Meu-cinn for Gastric Mucosal Health in Adults With Functional Dyspepsia

NCT06630455 ·Status: RECRUITING ·Phase: NA

A Relevance Study Between the Result of Clinical Drug Intervention and Next-generation Sequencing Technology Focused on Refractory Helicobacter Pylori Infection

NCT02806674 ·Status: UNKNOWN ·Phase: NA

Symptoms and Endoscopic Results in Consideration of Pretreatment

NCT00612404 ·Status: COMPLETED

Treatment of Atrophic Gastritis After HP Eradication With Modified Liujunzi Decoction Based on Syndrome Differentiation

NCT05388890 ·Status: RECRUITING

Symptoms and Physiological Effects of Amara in Functional Dyspepsia

NCT05553587 ·Status: COMPLETED ·Phase: PHASE4

Effect of Gastrogenic Microbiota in FD

NCT06760897 ·Status: COMPLETED ·Phase: NA

Effect of H. Pylori Eradication on Alleviating Symptoms in Functional Dyspepsia Patients

NCT05786807 ·Status: UNKNOWN ·Phase: PHASE4

H. Pylori Eradication on Healing of Iatrogenic Gastric Ulcer by Endoscopic Mucosal Resection

NCT00926809 ·Status: UNKNOWN ·Phase: PHASE4

Additive Effect of Endonase on Eradication Rate of First Line Therapy for Helicobacter Pylori

NCT01645761 ·Status: COMPLETED ·Phase: NA

Effect of H. Pylori Eradication on the Reversibility of Atrophic Gastritis and Intestinal Metaplasia in Korean Patients

NCT02691637 ·Status: COMPLETED

Change of Gut Microbiome and Symptom After H.Pylori Eradication Therapy in Patients With Functional Dyspepsia

NCT04449185 ·Status: UNKNOWN ·Phase: PHASE4

Effectiveness and Safety in Administrating CNU® Capsule to Refractory Functional Dyspepsia Patients

NCT03844100 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Usefulness of Serum Pepsinogen and Gastrin as the Predictive Biomarker of Atrophic Gastritis, Intestinal Metaplasia and Gastric Cancer in Korea

NCT02184910 ·Status: UNKNOWN

Clinical Characteristics, Lifestyle and Multi-omics Analysis in Autoimmune Gastritis

NCT05820607 ·Status: UNKNOWN

Efficacy of Galeo® in Patients With Postprandial Distress Syndrome Subtype in Functional Dyspepsia

NCT05199441 ·Status: COMPLETED ·Phase: PHASE4

Efficacy of Motilitone on Gastric Emptying in Patients With Functional Dyspepsia: Evaluation Using MRI Method

NCT02151708 ·Status: UNKNOWN ·Phase: NA

Clinical Study of Umbilical Cord Blood Mononuclear Cell Therapy for the Treatment of Chronic Atrophic Gastritis

NCT05808010 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Impact of the Introduction of a Gastro-intestinal Panel by Polymerase Chain Reaction (PCR).

NCT03551340 ·Status: COMPLETED